Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for vitamin root_names_name in Any Name (approximate match)

Showing 7071 - 7080 of 7136 results

First page
Previous page
Next page
Next page

INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

KJA387FHB2

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

First approved in 2013

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

NY1FF92M1E

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

First approved in 2013

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

P8ORN3UOM6

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

First approved in 2013

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

IBB8KGB0WJ

Status:

Possibly Marketed Outside US

Source:

BLA125163

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

First approved in 2013

Source:

BLA125163

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Y8O4RY7EEM

Status:

Possibly Marketed Outside US

Source:

BLA125163

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

First approved in 2013

Source:

BLA125163

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)

H41XP0E6G8

Status:

Possibly Marketed Outside US

Source:

BLA103837

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3b6dc88-d588-4cf4-97f2-3aa75b9e3e8b

First approved in 2013

Source:

BLA103837

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3b6dc88-d588-4cf4-97f2-3aa75b9e3e8b

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

3872LLC68G

Status:

Possibly Marketed Outside US

Source:

BLA103837

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3b6dc88-d588-4cf4-97f2-3aa75b9e3e8b

First approved in 2013

Source:

BLA103837

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3b6dc88-d588-4cf4-97f2-3aa75b9e3e8b

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

8KSK0802BP

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2009)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

First approved in 2009

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

KMO6TK08J4

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2009)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

First approved in 2009

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

3NZW5ND3D6

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2009)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

First approved in 2009

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

Showing 7071 - 7080 of 7136 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1